About us

Product overview

Browse our products ranging within diabetes, obesity, haemophilia, human growth hormone and hormone replacement therapy.

Insulin pens

NovoPen Echo®

The NovoPen Echo® is a durable pen designed to help your child manage his/her insulin dosing more confidently.

NovoPen® 5

With the additional benefit of an easy-to-use memory function, the NovoPen® 5 builds on the strong design and performance of its predecessor, the popular NovoPen® 4.

NovoPen® 4

NovoPen® 4 is the world’s most used durable pen device; refined and updated through more than 25 years of experience with millions of people with diabetes worldwide.

Pre-filled insulin delivery systems

FlexTouch®

U100, U200 FlexTouch® is the result of our patient-centric approach to research & development.

FlexPen®

FlexPen® has, for over a decade, been helping millions of patients with diabetes worldwide to inject their insulin.

InnoLet®

Needles

NovoFine®

NovoFine® comes in different lengths and widths. It is a thin, screw-on needle that is simple to use.

NovoFine® Plus®

NovoFine® Plus® is an ultra-thin, ultra-short needle that injects quickly and easily, and is suitable for people of all ages and weight.

NovoTwist®

NovoTwist® is designed for simplicity, reliability and user-friendliness to address real patient concerns.

NovoFine® AutoCover®

NovoFine® Autocover® is a simple screw-on needle with an automatic safety shield cover that helps to make you feel more comfortable about your injections, and reduces the risk of cross infection and needle injuries.

Other insulin delivery systems

PumpCart®

Cartridge to be used in pump

GlucaGen®

Glucagon

NovoRapid®

Cartridge to be used in pump

GlucaGen® hypokit

Glucagon emergency kit for severe hypoglycaemia

Vial

Diabetes

Treatments

Long-acting insulin

Tresiba®, insulin degludec Xultophy®*, insulin degludec/liraglutide Levemir®, insulin detemir

Human insulin

Insulatard®, human insulin Actrapid®, human insulin Mixtard® 30, biphasic human insulin Mixtard® 40, biphasic human insulin Mixtard® 50, biphasic human insulin

Premix insulin

Ryzodeg® 70/30, insulin degludec/insulin aspart NovoMix® 30, biphasic insulin aspart NovoMix® 50, biphasic insulin aspart NovoMix® 70, biphasic insulin aspart

Glucagon-like peptide-1 (GLP-1)

Rybelsus, oral semaglutide Victoza®, liraglutide Ozempic®, semaglutide

Fast-acting insulin

Fiasp®, insulin aspart NovoRapid® **, insulin aspart NovoRapid® PumpCart®, pre-filled insulin pump cartridge

Oral antidiabetic agents

NovoNorm®, repaglinide

Obesity

Saxenda®

Liraglutide 3 mg

Haemophilia

NovoSeven®

Recombinant factor VIIa

NovoEight®***

Recombinant factor VIII

NovoThirteen®

Recombinant factor XIII

Refixia®****

Nonacog beta pegol; N9/GP

Esperoct®1

Turoctocog alfa pegol, N8-GP

Growth disorders

Norditropin®

Somatropin (rDNA origin)

Macrilen™

Macimorelin; growth hormone secretagogue receptor agonist.

Norditropin® FlexPro®

Pre-filled multi-dose delivery system.

Norditropin® NordiFlex®

Pre-filled multi-dose delivery system

Norditropin® NordiLet®

Pre-filled multi-dose delivery system.

Norditropin® SimpleXx®

Pre-filled multi-dose delivery system.

Norditropin® SimpleXx®

Durable multi-dose delivery system

PenMate®

Automatic needle inserter

Hormone replacement therapy

Vagifem®

Estradiol hemihydrate

Activelle®

Estradiol/norethisterone acetate

Kliogest®

Estradiol/norethisterone acetate

Novofem®

Estradiol/norethisterone acetate

Trisequens®

Estradiol/norethisterone acetate

Estrofem®

Estradiol

Instructions for use

Since providing the world’s first injection system more than 90 years ago, we have been committed to making drug delivery as simple and convenient as possible. On this page you will find the instructions for use (IFU) for our durable pens and devices in your language. Our full range may not be available in your country. Please ask your doctor or nurse if you have any questions.

About this overview

This page is using European product trade names with accompanying generic names. Trade and generic names may differ in other markets.

Links to more details on the European Medicines Agency's (EMA) webpage are provided for those products that have been granted a central marketing authorisation by the European Commission.

Notes

* in the US approved under the brand name Xultophy® 100/3.6.

** in the US called NovoLog®

*** in the US spelt Novoeight®

**** in the US approved under the name of REBINYN®

1 approved in the US and received positive opinion in EU